GAAPP Annual Scientific Meeting
The 2023 Annual Scientific Meeting was conducted in a hybrid format (live streaming and in-person) in Le Méridien Hamburg, Germany, on 8 June 2023, before the EAACI Conference.
Video-recording:
You can watch the recording of the whole session below. Open the video on Youtube by clicking “Watch on YouTube” or clicking this link so you can access, through the video description, each presentation directly.
Summary of the Sessions
Unmet Needs in Urticaria
CU. Dr. Bernstein highlighted the seven C’s of managing chronic urticaria. Confirm. Cause. Cofactors. Comorbidities. Consequences. Components. Course. He also provided insight into the pipeline products that will transform care once approved.
Holistic Approaches to Food Allergy
Food Allergy. Dr. Jones addressed the needs of the person living with food allergies & the family-centered, holistic approach he takes in his clinic. He emphasized the latest evidence-based approaches to prevention, diagnosis, treatment, and management with a values-based approach and shared decision-making.
What’s New in Atopic Dermatitis
Atopic Dermatitis. Dr Glick explained how far we have come in the last ten years in the diagnosis & treatment of AD. Moreover, he explained how more than one hundred products are currently under investigation for use in this condition, providing additional hope for the three hundred million impacted globally.
Environmental Influences in Allergy and Asthma
Allergy & Asthma Epigenetics. Dr. Holloway helped us understand the interplay between genetics & environment for the almost one billion people living with allergies and/or asthma. The science regarding maternal & paternal exposures while in utero is expanding rapidly, allowing us to intercede earlier in one’s life to minimize the impact of atopic & airway diseases.
COPD & Asthma: New Horizons and Hope
GINA & GOLD 2023 Updates. Dr. Arora provided high-level key takeaways from the most recent global consensus reports. From recommending new inhaler terminology to challenging the concept of “mild asthma”, her 15 points allowed us to consider how we help our communities access the best care. On the COPD front, she shared the movement away from ABCD staging to ABE staging of the disease and introduced the concept of seven unique endotypes/phenotypes in COPD.
It was four hours of scientific updates & expert opinions, which will advance all of our work for the year to come!
With generous support from our Sponsors:
